The UAE government has initiated a month-long public consultation to gather expert feedback on the regulation of non-human organ and tissue transplants. Following legal amendments passed in December 2025 that expanded the scope of transplantation to include animal-derived and manufactured organs, authorities are now looking to establish a robust framework to manage this complex medical frontier. Stakeholders are invited to share their insights on safety standards, ethical considerations, and the practical implementation of these procedures, ensuring the country remains aligned with international medical practices while prioritizing patient welfare.

This legislative shift aims to modernize the nation's healthcare infrastructure by incorporating cutting-edge advancements like xenotransplantation and bioengineered materials. Under the updated decree, any use of non-human organs is strictly conditional, requiring official licensing, thorough laboratory testing, and informed patient consent to mitigate potential risks. With significant legal penalties, including heavy fines and imprisonment for non-compliance, the UAE is emphasizing accountability and rigorous oversight to ensure that these emerging technologies are integrated safely and transparently into the healthcare system.